ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1950

Morbidities Associated with Serious Infections in Patients with Rheumatoid Arthritis

Bradly Kimbrough1, Cynthia Crowson2, Ryan Lennon3, John Davis3 and Elena Myasoedova3, 1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Eyota, MN, 3Mayo Clinic, Rochester, MN

Meeting: ACR Convergence 2022

Keywords: Comorbidity, Infection, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster IV

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk for serious infections. Several infection risk scores have been developed over the last decade for patients with RA. These scores are largely based on a combination of patient demographics, medications, and a limited list of morbidities. Patients with RA have a higher prevalence of multimorbidity compared with non-RA patients, and some morbidities associated with the risk of infection may remain unaccounted in the existing infection risk scores. Thus, in this study we aimed to examine associations between a comprehensive list of morbidities and the risk of serious infection in patients with RA.

Methods: This population-based cohort study included patients from a geographically well-defined area with incident RA from 1/1/1995 through 7/1/2015 meeting the 1987 American College of Rheumatology criteria. Patients were followed until the earlier of: death, migration from the region, or 07/01/2015. Serious infections requiring hospitalization were identified using ICD-9 codes. The presence of fifty-five potential co-morbidities was then ascertained, requiring two separate ICD-9 codes at least 30 days apart. Conditional frailty models (a variation of Cox model that accounts for multiple events per patient) were used to analyze the association between each morbidity and serious infection, adjusting for age, sex, and calendar year. Hazard ratios with 95% confidence intervals (95%CI) were determined for each morbidity.

Results: There were 911 patients (70% female, mean age 56 years) who met inclusion criteria. During the 5,492 person years of observation, there were 209 serious infections resulting in an incidence of 3.8 infections per 100 person-years. One hundred and sixteen patients (13%) had at least one hospitalization for serious infection. The most common morbidities (% of patients; % person-years) included hypertension (48.4%; 38.6%), hyperlipidemia (48.1%; 34.6%), osteoarthritis (47.5%; 29.1%), and chronic back pain (46.7%; 28.1%). Twenty-nine of the 55 morbidities assessed were associated with an increased the risk of serious infection (Table). Comorbidities conferring the highest risk include bipolar disorder (HR 5.54; 95%CI 1.46 to 21.11), chronic kidney disease (HR 5.15; 95%CI 2.81 to 9.44), skin ulcers (HR 3.90; 95%CI 1.54 to 9.87), and chronic obstructive pulmonary disease (HR 3.88; 95%CI 2.33 to 6.47).

Conclusion: This population-based study highlights several morbidities associated with increased risk of serious infections in patients with RA. Future studies may aim to combine a similar comprehensive comorbidity risk profile with other known infection risk factors such as medications and smoking status to create improved predictive models for serious infection.

Supporting image 1


Disclosures: B. Kimbrough, None; C. Crowson, None; R. Lennon, None; J. Davis, Pfizer; E. Myasoedova, None.

To cite this abstract in AMA style:

Kimbrough B, Crowson C, Lennon R, Davis J, Myasoedova E. Morbidities Associated with Serious Infections in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/morbidities-associated-with-serious-infections-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/morbidities-associated-with-serious-infections-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology